Heart valve study shows strong safety in chinese patients

NCT ID NCT05330468

Completed Disease control Sponsor: Abbott Medical Devices Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how safe and effective Abbott's Regent mechanical heart valve is for Chinese patients needing a new aortic valve. Researchers followed 200 adults who received the valve to track valve-related deaths and the need for repeat surgery. The goal was to confirm the valve works well in this population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC VALVE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aortic Valve Disease aortic valve disorder heart valve disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC VALVE DISEASE VALVULAR HEART DISEASE

Contacts and locations

Locations

Affiliated Hospital of Zunyi Medical University

Zunyi, China
Ningbo Medical Center Lihuili Hospital

Ningbo, China
The People's Hospital of Gaozhou

Gaozhou, China
The Second Affiliated Hospital of Nanchang University

Nanchang, China
Wuhan Union Hospital of China

Wuhan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.